Trillium Therapeutics Inc. 4 SEC Filings

Filed On	Filing
19 Nov 2021	Form 4: Walker Paul Edward, Director Returned 5,736,363 shares to the issuer · Disposed of 850,000 Warrant to Purchase Common Shares (Disposition to Issuer) · Disposed of 6,750,000 Series II Non-Voting Convertible First Preferred Shares (Disposition to Issuer) · 2 more
19 Nov 2021	Form 4: Pucci Paolo, Director Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Myers Scott Dunseth, Director Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Harrison Rosemary, See Remarks Returned 75 shares to the issuer · Disposed of 180,000 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Beshar Luke M, Director Disposed of 46,666 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 547,656.26 Deferred Share Unit (Disposition to Issuer)
19 Nov 2021	Form 4: Parsons James T., Chief Financial Officer Disposed of 461,385 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Kamarck Michael E., Director Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Looker Benjamin, General Counsel Disposed of 190,000 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Mackey Catherine J, Director Disposed of 67,000 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Bruns Ingmar, Chief Medical Officer Disposed of 400,000 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Petrova Penka, Chief Development Officer Disposed of 316,822 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Uger Robert, Chief Scientific Officer Disposed of 468,222 Stock Option (Right to Buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Tayton-martin Helen Katrina, Director Disposed of 40,000 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 498,294.287 Deferred Share Unit (Disposition to Issuer)
19 Nov 2021	Form 4: Skvarka Jan, Director Disposed of 1,959,500 Stock Option (Right to Buy) (Disposition to Issuer)
09 Jul 2021	Form 4: Uger Robert, Chief Scientific Officer Received 3,646 shares by exercise or conversion ($1.11K) · Sold 3,646 shares ($32.8K)
02 Jul 2021	Form 4: Mackey Catherine J, Director Granted 67,000 Stock Option (Right to Buy)
09 Jun 2021	Form 4: Uger Robert, Chief Scientific Officer Received 3,646 shares by exercise or conversion ($1.15K) · Sold 3,646 shares ($30.2K)
13 May 2021	Form 4: Skvarka Jan, Director Received 106,698 shares by exercise or conversion ($45.1K) · Sold 106,698 shares ($982K) · Received 23,802 shares by exercise or conversion ($7.47K) · 1 more
11 May 2021	Form 4: Uger Robert, Chief Scientific Officer Received 3,646 shares by exercise or conversion ($1.14K) · Sold 3,646 shares ($33.9K)
05 May 2021	Form 4: Looker Benjamin, General Counsel Granted 190,000 Stock Option (Right to Buy)

Comments